ATE66247T1 - Wiederhergestellter basalmembrankomplex mit biologischer aktivitaet. - Google Patents

Wiederhergestellter basalmembrankomplex mit biologischer aktivitaet.

Info

Publication number
ATE66247T1
ATE66247T1 AT86111635T AT86111635T ATE66247T1 AT E66247 T1 ATE66247 T1 AT E66247T1 AT 86111635 T AT86111635 T AT 86111635T AT 86111635 T AT86111635 T AT 86111635T AT E66247 T1 ATE66247 T1 AT E66247T1
Authority
AT
Austria
Prior art keywords
cells
nidogen
entactin
biologically active
composition
Prior art date
Application number
AT86111635T
Other languages
English (en)
Inventor
Hynda Karen Kleinman
George Reilly Martin
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE66247T1 publication Critical patent/ATE66247T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/70—Undefined extracts
    • C12N2500/80—Undefined extracts from animals
    • C12N2500/84—Undefined extracts from animals from mammals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
AT86111635T 1985-08-30 1986-08-22 Wiederhergestellter basalmembrankomplex mit biologischer aktivitaet. ATE66247T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77140985A 1985-08-30 1985-08-30
US06/867,027 US4829000A (en) 1985-08-30 1986-05-27 Reconstituted basement membrane complex with biological activity
EP86111635A EP0218065B1 (de) 1985-08-30 1986-08-22 Wiederhergestellter Basalmembrankomplex mit biologischer Aktivität

Publications (1)

Publication Number Publication Date
ATE66247T1 true ATE66247T1 (de) 1991-08-15

Family

ID=27118460

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86111635T ATE66247T1 (de) 1985-08-30 1986-08-22 Wiederhergestellter basalmembrankomplex mit biologischer aktivitaet.

Country Status (6)

Country Link
US (1) US4829000A (de)
EP (1) EP0218065B1 (de)
JP (1) JPH0740932B2 (de)
AT (1) ATE66247T1 (de)
CA (1) CA1291432C (de)
DE (1) DE3680851D1 (de)

Families Citing this family (175)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037656A (en) * 1986-12-04 1991-08-06 Millipore Corporation Porous membrane having hydrophilic and cell growth promotions surface and process
US5541076A (en) * 1988-12-12 1996-07-30 Bard Diagnostic Sciences, Inc. Methods for determining the invasiveness of a bladder tumor
US5512657A (en) * 1988-12-12 1996-04-30 Bainbridge Sciences, Inc. Detection of complexes which include basement membrane components as diagnostic of cancer and other diseases
AU6872691A (en) * 1989-10-27 1991-05-31 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
US5869266A (en) * 1990-03-06 1999-02-09 The United States Of America As Represented By The Department Of Health And Human Services Human olfactory neuron cultures to diagnose Alzheimer's disease
AU7656991A (en) * 1990-03-30 1991-10-30 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method and composition for growing tumors from few cells
US6133236A (en) * 1991-03-26 2000-10-17 Oregon Health Sciences University Products and methods for improving keratinocyte adhesion to the dermis
EP0579742A4 (en) * 1991-03-26 1994-07-13 Oregon State Product and method for improving keratinocyte adhesion to the dermis
US5770562A (en) * 1991-03-26 1998-06-23 Oregon Health Sciences University Products and methods for improving keratinocyte adhesion to the dermis
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5354666A (en) * 1991-08-01 1994-10-11 Thomas Jefferson University Mammalian cell line expressing basement membrane proteins
US5547997A (en) * 1991-10-01 1996-08-20 Chemisches Laboratorium Dr. Kurt Richter Gmbh Plant-derived cosmetic composition and method of treatment of skin
US5175103A (en) * 1991-10-21 1992-12-29 Trustees Of University Of Pennsylvania Preparation of pure cultures of post-mitotic human neurons
US5508188A (en) * 1994-01-21 1996-04-16 The Regents Of The University Of California Method of growing cells in a mammal
EP0755258B1 (de) * 1994-04-13 2002-01-23 Research Corporation Technologies, Inc Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
US5763255A (en) * 1994-04-25 1998-06-09 Becton Dickinson And Company Inducing epithelial cell differentiation with dried native fibrillar collagen
US5853717A (en) * 1994-07-20 1998-12-29 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US5935849A (en) * 1994-07-20 1999-08-10 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
EP0781297A4 (de) * 1994-09-16 1999-05-19 Scripps Research Inst Cytotactin-derivate, welche neuronale verbindungen und das neuritenwachstum fördern und verfahren ihrer produktion und anwendung
US5695998A (en) * 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US6485723B1 (en) 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
US5830460A (en) 1995-03-13 1998-11-03 University Of South Florida Sertoli cells as transplantation facilitator for cell transplantation
US6495364B2 (en) * 1995-05-23 2002-12-17 Neurotech, S.A. Mx-1 conditionally immortalized cells
JP5053470B2 (ja) * 1996-08-23 2012-10-17 クック バイオテク インコーポレイティド グラフト・プロテーゼとその材料及び方法
JP4046358B2 (ja) 1996-12-10 2008-02-13 パーデュー・リサーチ・ファウンデーション 粘膜下組織抽出物
CA2274033C (en) 1996-12-10 2010-05-11 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US6696270B2 (en) 1996-12-10 2004-02-24 Purdue Research Foundation Gastric submucosal tissue as a novel diagnostic tool
US6152142A (en) 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US6074874A (en) * 1997-08-29 2000-06-13 University Of Pittsburgh Epithelial cell cultures for in vitro testing
US6485969B1 (en) 1997-12-23 2002-11-26 Purdue Research Foundation Biomaterial derived from follicle basement membranes
WO1999043786A2 (en) * 1998-02-27 1999-09-02 Purdue Research Foundation Submucosa gel compositions
US6667176B1 (en) * 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US7410798B2 (en) * 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
US7399751B2 (en) * 1999-11-04 2008-07-15 Sertoli Technologies, Inc. Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
WO2000047129A2 (en) 1999-02-11 2000-08-17 The General Hospital Corporation Microfabricated membranes and matrices
US6815203B1 (en) * 1999-06-23 2004-11-09 Joslin Diabetes Center, Inc. Methods of making pancreatic islet cells
DE10003521A1 (de) 2000-01-27 2001-08-09 Medigene Ag Vorrichtung zum Herstellen eines dreidimensionalen Matrixkörpers, Multi-Well-Platte, Lösung zum Kultivieren von Säugerkardiomyocyten, Verfahren zum Kultivieren einer Zellkultur, Vorrichtung für die Messung isometrischer Kraftparameter von Zellkulturen sowie Verfahren zum meßbaren Verfolgen von Kontraktionen eines in eine Trägersubstanz eingelagerten Zellgewebes
DE10010113B4 (de) * 2000-03-03 2009-05-07 Wolfgang Dr. Schatton Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung
AU8843701A (en) * 2000-09-09 2002-03-22 Univ New York State Res Found Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
US6740501B2 (en) * 2000-09-27 2004-05-25 Becton, Dickinson And Company Coated membrane for assessing the invasive capacity of a cell
EP2206772A3 (de) * 2000-12-06 2010-08-04 Robert J. Hariri Verfahren zum Sammeln von Plazentastammzellen
EP2336299A1 (de) * 2001-02-14 2011-06-22 Anthrogenesis Corporation Post-partum Säugetier-Plazenta, deren Verwendung und daraus gewonnene Stammzellen
CA2388723C (en) * 2001-06-06 2012-10-23 Becton, Dickinson & Company Method of providing a substrate with a ready-to-use, uniformly distributed extracellular matrix
US6706520B2 (en) 2001-06-13 2004-03-16 Kehan Han Assessment of invasive potential of tumor cells
AU2002320189B2 (en) * 2001-06-28 2007-04-26 Cook Biotech Incorporated Graft prosthesis devices containing renal capsule collagen
US20050244843A1 (en) * 2001-11-16 2005-11-03 Wen-Tien Chen Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
WO2003059061A1 (en) * 2002-01-11 2003-07-24 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US7700090B2 (en) 2002-02-13 2010-04-20 Anthrogenesis Corporation Co-culture of placental stem cells and stem cells from a second source
CA2479840A1 (en) * 2002-04-02 2003-10-16 William Marsh Rice University Redifferentiated cells for repairing cartilage defects
JP2005533535A (ja) * 2002-05-02 2005-11-10 パーデュー・リサーチ・ファウンデーション 血管新生が促進された移植片構成物
CN1684589A (zh) * 2002-05-02 2005-10-19 普渡研究基金会 血管化增强的移植构造物
EP2103684A1 (de) * 2002-05-02 2009-09-23 Purdue Research Foundation Gefäßneubildungserweiterte Transplantationskonstrukte
PT1541674E (pt) * 2002-06-18 2011-03-21 Eisai R&D Man Co Ltd Adipócitos cultivados em primário para terapia génica
JP2004075661A (ja) * 2002-06-18 2004-03-11 Shiseido Co Ltd 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法
KR101042448B1 (ko) 2002-11-26 2011-06-16 안트로제네시스 코포레이션 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법
US20040191226A1 (en) * 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of body wall
US20040187877A1 (en) * 2002-12-04 2004-09-30 Badylak Stephen F. Method for repair of liver tissue
US20060251630A1 (en) * 2002-12-24 2006-11-09 An-Go-Gen Inc. Encapsulated cell therapy
US7727550B2 (en) * 2003-02-21 2010-06-01 The Uab Research Foundation Biologically active native biomatrix composition
US20040176855A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation
WO2005014619A2 (en) 2003-03-28 2005-02-17 Thomas Jefferson University Heparin-binding peptides and uses thereof
US20050025838A1 (en) * 2003-06-25 2005-02-03 Badylak Stephen F. Conditioned compositions for tissue restoration
CA2848954A1 (en) * 2003-07-03 2005-03-03 Sertoli Technologies, Llc Compositions containing sertoli cells and myoid cells and use thereof in cellular transplants
US7608455B2 (en) 2003-08-20 2009-10-27 Becton, Dickinson And Company Modified reconstituted basement membrane composition for assay system
US20050079611A1 (en) * 2003-08-20 2005-04-14 Min Wu Modified reconstituted basement membrane composition for assay system
GB0321337D0 (en) * 2003-09-11 2003-10-15 Massone Mobile Advertising Sys Method and system for distributing advertisements
WO2005027846A2 (en) * 2003-09-18 2005-03-31 Alexion Pharmaceuticals, Inc. Elicitation of antibodies to self peptides in mice by immunization with dendritic cells
US20050208627A1 (en) * 2003-09-18 2005-09-22 Bowdish Katherine S Elicitation of antibodies to self peptides in mice by immunization with dendritic cells
NZ547140A (en) 2003-10-22 2009-09-25 Encelle Inc Bioactive hydrogel compositions in dehydrated form for regenerating connective tissue
AU2004286307A1 (en) * 2003-10-31 2005-05-12 Vitatex, Inc. Blood test prototypes and methods for the detection of circulating tumor and endothelial cells
US8916184B2 (en) 2003-11-07 2014-12-23 University Of Connecticut Artificial tissue systems and uses thereof
KR20070002067A (ko) * 2004-03-26 2007-01-04 셀진 코포레이션 줄기 세포 은행의 제공 시스템 및 제공 방법
AU2005231781A1 (en) * 2004-03-31 2005-10-20 Cook Incorporated ECM-based graft material
US8377484B1 (en) 2004-05-06 2013-02-19 Maria V. Tsiper Tumor encapsulation for prevention and treatment of metastatic cancer disease
WO2005121316A1 (en) * 2004-06-11 2005-12-22 Bernard O'brien Institute Of Microsurgery Tissue material and muscle derived matrix
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
ES2427565T3 (es) 2005-04-25 2013-10-31 Massachusetts Institute Of Technology Péptidos autoensambladores para promover la hemostasia
US20060252149A1 (en) * 2005-05-06 2006-11-09 Orion Biosolutions, Inc. Cns cells in vitro
US8048446B2 (en) * 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
WO2006138718A2 (en) 2005-06-17 2006-12-28 Drexel University Three-dimensional scaffolds for tissue engineering made by processing complex extracts of natural extracellular matrices
CN101316602B (zh) 2005-09-27 2015-06-03 组织技术公司 羊膜制品和纯化的组合物及其使用方法
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
CA2624925C (en) 2005-10-13 2014-09-30 Anthrogenesis Corporation Immunomodulation using placental stem cells
US20070190165A1 (en) * 2005-10-21 2007-08-16 Brey Eric M Tissue-specific basement membrane gels
ES2708933T3 (es) 2005-12-29 2019-04-12 Celularity Inc Poblaciones de células madre placentarias
HUE037994T2 (hu) 2006-04-25 2018-09-28 Massachusetts Inst Technology Készítmények és eljárások szennyezõ anyagok, testfolyadékok vagy más anyagok mozgásának befolyásolására és/vagy más fiziológiai állapotok befolyásolására
KR101569168B1 (ko) 2007-02-12 2015-11-13 안트로제네시스 코포레이션 태반 줄기세포를 이용한 염증 질환의 치료
CA2677679A1 (en) * 2007-02-12 2008-08-21 Anthrogenesis Corporation Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations
EP2146733B1 (de) 2007-03-14 2020-11-25 Arch Biosurgery, Inc. Behandlung von leckenden oder beschädigten engen verbindungen und verstärkung der extrazellulären matrix
TWM322542U (en) * 2007-05-23 2007-11-21 Universal Scient Ind Co Ltd Testing machine
DE102007026639A1 (de) 2007-06-06 2008-12-11 Stefan-Andreas Ulrich Industrielle Fertigung tierischer Lederhautsubstitute für die Lederproduktion aus etablierten Epithelzelllinien und/oder primären Epithelzellkulturen, wie vorzugsweise Fibroplasten, Melanozyten, Keratiozyten sowie deren Verfahren und Vorrichtungen
US9200253B1 (en) 2007-08-06 2015-12-01 Anthrogenesis Corporation Method of producing erythrocytes
WO2009029578A2 (en) * 2007-08-27 2009-03-05 Shell Oil Company A carrier, a process for preparing the carrier, an olefin epoxidation catalyst, a process for preparing the catalyst, and a process for the production of an olefin oxide, a 1,2-diol, a 1,2-diol ether, or an alkanolamine
WO2009042768A1 (en) * 2007-09-25 2009-04-02 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Triggerably dissolvable hollow fibers for controlled delivery
CA2700617C (en) 2007-09-28 2018-11-06 Celgene Cellular Therapeutics Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
EP2222159B1 (de) 2007-11-20 2018-02-21 Pioneer Surgical Orthobiologics, Inc. Kryokonservierung von zellen mittels vernetzten bioaktiven hydrogel matrixteilchen
EP2215216B1 (de) 2007-12-03 2018-05-30 SanBio, Inc. Extrazelluläre matrix aus pluripotenten zellen
WO2009098698A2 (en) 2008-02-07 2009-08-13 Shahar Cohen Compartmental extract compositions for tissue engineering
DK2330889T3 (en) 2008-08-20 2017-01-30 Anthrogenesis Corp Improved cell composition and process for making the same
JP5950577B2 (ja) * 2008-08-20 2016-07-13 アンスロジェネシス コーポレーション 単離胎盤細胞を使用した脳卒中の治療
HRP20130812T1 (en) 2008-08-22 2013-09-30 Anthrogenesis Corporation Methods and compositions for treatment of bone defects with placental cell populations
US20110172159A1 (en) * 2008-09-05 2011-07-14 Coelho De Sampaio Tatiana Lobo Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment
CN102282252B (zh) 2008-11-19 2017-07-04 人类起源公司 羊膜来源的贴壁细胞
EP2403438B1 (de) 2009-03-04 2021-04-21 Peytant Solutions, Inc. Mit amniongewebehaltigem material modizifierte stents und zugehörige verfahren
US8586360B2 (en) 2009-07-02 2013-11-19 Anthrogenesis Corporation Method of producing erythrocytes without feeder cells
US8652500B2 (en) 2009-07-22 2014-02-18 Acell, Inc. Particulate tissue graft with components of differing density and methods of making and using the same
US8298586B2 (en) 2009-07-22 2012-10-30 Acell Inc Variable density tissue graft composition
BR112012009801A8 (pt) 2009-10-30 2016-08-30 Cns Therapeutics Inc Polipeptídeo neurturina e variante de neurturina
ES2646750T3 (es) 2010-01-26 2017-12-15 Anthrogenesis Corporation Tratamiento de cánceres relacionados con hueso utilizando células madre placentarias
US8778416B2 (en) 2010-02-10 2014-07-15 Nayacure Therapeutics Ltd. Pharmaceutical compositions and methods for the treatment and prevention of cancer
IL250234B2 (en) 2010-04-07 2023-10-01 Anthrogenesis Llc Angiogenesis using placental stem cells
MX2012011543A (es) 2010-04-08 2013-05-06 Anthrogenesis Corp Tratamiento de sarcoidosis empleando celulas madre placentarias.
KR20180099915A (ko) 2010-07-13 2018-09-05 안트로제네시스 코포레이션 천연 킬러 세포의 생성 방법
WO2012027592A2 (en) * 2010-08-25 2012-03-01 Lifenet Health Basement membrane compositions and applications thereof
AU2011352036A1 (en) 2010-12-31 2013-07-18 Anthrogenesis Corporation Enhancement of placental stem cell potency using modulatory RNA molecules
CN104220081A (zh) 2011-06-01 2014-12-17 人类起源公司 利用胎盘干细胞治疗疼痛
EP2717888B1 (de) 2011-06-10 2020-09-09 Tissuetech, Inc. Verfahren zur verarbeitung fötaler gewebesubstrate
WO2013003234A1 (en) * 2011-06-28 2013-01-03 Trevigen, Inc. Tumor extract
WO2013055476A1 (en) 2011-09-09 2013-04-18 Anthrogenesis Corporation Treatment of amyotrophic lateral sclerosis using placental stem cells
EP2594635A1 (de) 2011-11-18 2013-05-22 Univercell Biosolutions Verfahren zur Erzeugung von kardiovaskulären Vorläuferzellen bei Primaten zur Verwendung bei klinischen und arzneimitteltechnischen Zelltests aus embryonalen Primatenstammzellen oder aus Zellen im embryoähnlichen Zustand sowie deren Anwendungen
MX352601B (es) 2011-12-23 2017-11-30 Pioneer Surgical Tech Matriz continua con particulas osteoconductoras dispersadas en ella, método para formarla y método para regenerar hueso con ella.
WO2013162828A1 (en) 2012-04-27 2013-10-31 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Use of cpg oligonucleotides co-formulated with an antibiotic to accelarate wound healing
US20140072510A1 (en) * 2012-09-13 2014-03-13 Northwestern University Synthetic Scaffolds for Metastasis Detection
EP2743345A1 (de) 2012-12-13 2014-06-18 IMBA-Institut für Molekulare Biotechnologie GmbH Dreidimensionale heterogen differenzierte Gewebekultur
AU2014215458A1 (en) 2013-02-05 2015-08-13 Anthrogenesis Corporation Natural killer cells from placenta
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
JP2016516091A (ja) 2013-04-02 2016-06-02 ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド 血管新生の誘導および調節のための組成物および方法、ならびに血管新生調節因子を同定する方法およびアッセイ
WO2015171880A1 (en) * 2014-05-08 2015-11-12 The University Of Florida Research Foundation, Inc. Sustained release angiogenesis modulating compositions and methods for induction and modulation of angiogenesis
CN105658252A (zh) 2013-08-22 2016-06-08 阿奇生物外科有限公司 用于控制流体移动的可植入网状物
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
AU2015209434A1 (en) 2014-01-22 2016-08-04 Zpredicta, Inc. Method and apparatus for isolating invasive and metastatic cells for evaluating therapeutics and prediction of metastatic capacity
WO2015123132A1 (en) * 2014-02-12 2015-08-20 The Board Of Regents Of The University Of Texas System Three-dimensional silk fibroin scaffold culture retaining functional salivary cells and promoting salivary tissue-specific ecm synthesis
EP4548939A3 (de) 2014-08-27 2025-08-06 Purdue Research Foundation Abgabesysteme für therapeutikum auf kollagenbasis
US20160243288A1 (en) 2015-02-23 2016-08-25 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
WO2016146893A1 (en) 2015-03-17 2016-09-22 University Of Oulu Human tumor based extracellular matrix for cell studies in vitro
US11919941B2 (en) 2015-04-21 2024-03-05 Purdue Research Foundation Cell-collagen-silica composites and methods of making and using the same
NL2015130B1 (en) 2015-07-09 2017-02-01 Mimetas B V Barrier function measurements.
US12551509B2 (en) 2015-11-18 2026-02-17 Lucina Patent Holdco, Llc Acellular regenerative products and methods of their manufacture
EP3190176A1 (de) 2016-01-11 2017-07-12 IMBA-Institut für Molekulare Biotechnologie GmbH Verfahren zur gewebekulturentwicklung auf einem gerüst und differenzierte gewebekultur
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
JP2019503203A (ja) 2016-01-29 2019-02-07 アカオジェン インコーポレイテッド 細胞表面エピトープと結合する抗体を同定するためのスクリーニング方法
NL2016404B1 (en) 2016-03-09 2017-09-26 Mimetas B V Double tubular structures.
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
MX2018012719A (es) 2016-04-19 2019-05-30 Us Health Ram negativas para tratar la dermatitis atopica.
JP6967535B2 (ja) 2016-06-15 2021-11-17 ミメタス ビー．ブイ． 細胞培養装置及び方法
US20190169562A1 (en) * 2016-07-29 2019-06-06 Zpredicta, Inc. Screening of immuno-modulatory therapies
WO2018140827A1 (en) 2017-01-27 2018-08-02 Achaogen, Inc. Reporter microorganisms and uses thereof
ES3040675T3 (en) 2017-01-31 2025-11-04 Geniphys Inc Methods and compositions for matrix preparation
EP3395942A1 (de) 2017-04-25 2018-10-31 IMBA-Institut für Molekulare Biotechnologie GmbH Bi- oder multi-differenziertes organoid
US11739291B2 (en) 2017-04-25 2023-08-29 Purdue Research Foundation 3-dimensional (3D) tissue-engineered muscle for tissue restoration
AU2018285579B2 (en) 2017-06-16 2024-10-24 Imba - Institut Für Molekulare Biotechnologie Gmbh Blood vessel organoid, methods of producing and using said organoids
US11684698B2 (en) 2017-09-08 2023-06-27 Riken Cell aggregate including retinal tissue and production method therefor
CN111065732A (zh) 2017-09-11 2020-04-24 Imba-莫利库尔生物技术研究所 肿瘤类器官模型
US12480162B2 (en) 2017-10-06 2025-11-25 The Regents Of The University Of Michigan Detection of metastatic disease and related methods
WO2019083904A1 (en) 2017-10-23 2019-05-02 Chan Zuckerberg Biohub, Inc. AFUCOSYLATED IGG FC GLYCANES MEASUREMENT AND METHODS OF TREATMENT THEREOF
CA3099903A1 (en) 2018-05-11 2019-11-14 Forte Subsidiary, Inc. Compositions for the treatment of skin conditions
NL2022085B1 (en) 2018-11-28 2020-06-25 Mimetas B V Device for assessing mechanical strain induced in or by cells
GB201900930D0 (en) 2019-01-23 2019-03-13 Res & Innovation Uk Choroid plexus organoids and methods for productions thereof
EP3689971A1 (de) 2019-02-04 2020-08-05 Real Research Sp. z o.o. Proteinhydrogel, herstellungsverfahren und verwendung davon
US12221630B2 (en) 2019-02-19 2025-02-11 Miltenyi Biotec B.V. & Co. KG Cell culture medium and method for generation of epithelial organoids from epithelial stem cells
EP3947637A1 (de) * 2019-04-04 2022-02-09 THT Biomaterials GmbH Neuartige, auf humanmaterial basierende plattformtechnologie für gewebezüchtung
IL271778A (en) 2019-12-31 2021-06-30 Ichilov Tech Ltd Methods for treating atopic dermatitis
CA3168904A1 (en) 2020-01-27 2021-08-05 Geniphys, Inc. Biologic filler for restoring and regenerating tissue
US20230138007A1 (en) * 2020-04-08 2023-05-04 Ichimaru Pharcos Co., Ltd. Unit for angiogenesis promotion and/or nerve regeneration
NL2026038B1 (en) 2020-07-09 2022-03-15 Mimetas B V Microfluidic cell culture device
WO2023090427A1 (ja) 2021-11-19 2023-05-25 国立研究開発法人理化学研究所 シート状網膜組織の製造方法
EP4286513A1 (de) 2022-06-03 2023-12-06 IMBA-Institut für Molekulare Biotechnologie GmbH Dreifache gewebekulturfusion
CN115261302B (zh) * 2022-07-20 2023-06-06 创芯国际生物科技(广州)有限公司 一种基质胶及其制备方法和应用
CN121057811A (zh) 2023-03-29 2025-12-02 瑞克生乐有限公司 视网膜组织的制造方法
NL2035770B1 (en) 2023-09-08 2025-03-14 Mimetas B V Titerplate
US20260022331A1 (en) * 2024-07-22 2026-01-22 Preci LLC Methods of producing a tissue derived extracellular matrix hydrogel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280954A (en) * 1975-07-15 1981-07-28 Massachusetts Institute Of Technology Crosslinked collagen-mucopolysaccharide composite materials
US4642292A (en) * 1979-10-29 1987-02-10 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Method for isolation of connective tissue biomatrix

Also Published As

Publication number Publication date
DE3680851D1 (de) 1991-09-19
EP0218065B1 (de) 1991-08-14
JPS62129222A (ja) 1987-06-11
CA1291432C (en) 1991-10-29
US4829000A (en) 1989-05-09
EP0218065A3 (en) 1989-03-08
JPH0740932B2 (ja) 1995-05-10
EP0218065A2 (de) 1987-04-15

Similar Documents

Publication Publication Date Title
DE3680851D1 (de) Wiederhergestellter basalmembrankomplex mit biologischer aktivitaet.
Gross et al. Increased capillary endothelial cell protease activity in response to angiogenic stimuli in vitro.
Lash et al. An experimental analysis of the development of the spinal column: VI. Aspects of cartilage induction
Campbell et al. Recombinant human interleukin-1 stimulates human articular cartilage to undergo resorption and human chondrocytes to produce both tissue-and urokinase-type plasminogen activator
Buckingham et al. Progressive systemic sclerosis (PSS, scleroderma) dermal fibroblasts synthesize increased amounts of glycosaminoglycan
GEP20002145B (en) Stem Cell Factor
DE69533223D1 (de) Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo
EP0781092A4 (de) Verfahren zur sensibilisierung von tumorzellen mit adenoviruse1a
DE69635924D1 (de) Isolierung und züchtung von schwannzellen
Thawer et al. Effects of electrical stimulation on the histological properties of wounds in diabetic mice
IT1244879B (it) Estratti da tessuti animali, utili in terapia e in diagnostica.
DE69634499D1 (de) Verwendungsmethoden von einkernigen phagozyten zur förderung der axonalen regeneration
ZA895840B (en) N-2,3-butadienyl tri-and tetraaminoalkane derivatives
CN113576971B (zh) 一种纤连蛋白冻干粉制剂及其制备方法
Roberts et al. Glycoproteins and glycosaminoglycans synthesized by human keratinocytes in culture. Their role in cell-substratum adhesion
Doillon et al. Fibroblast and epidermal cell-type I collagen interactions: cell culture and human studies
NO882854L (no) Korreksjon med dobbeltraadet rna av avvikende metabolske spor forbundet med ukontrollerte vekstsykluser for tumorceller og virus.
Zelickson et al. Melanocyte changes following PUVA therapy
McGuire et al. Cell-cell interactions in the rheumatoid joint
Cymerman et al. Effects of increased oxygen tensions on bioelectric properties of frog sciatic nerve
Basdra et al. Mechanical loading triggers specific biochemical responses in mandibular condylar chondrocytes
FR2600671B1 (fr) Procede de conservation cryogenique de substances et matieres organiques, notamment de cellules
BR9709379A (pt) Uso de uridina, e, composição para o tratamento de distúrbios do sistema nervoso devido à degeneração seletiva de células neuroniais ou gliais em mamìferos.
Chen et al. Human keratinocytes make uniquely linear phagokinetic tracks
Shinmei et al. N6, O2′-dibutyryl adenosine 3′, 5′-monophosphate-stimulated release of proteoglycans from cultured immature rabbit ear cartilage

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time